17-10309279-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000252172.9(MYH13):āc.5124G>Cā(p.Gln1708His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,613,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00029 ( 0 hom., cov: 33)
Exomes š: 0.000029 ( 0 hom. )
Consequence
MYH13
ENST00000252172.9 missense
ENST00000252172.9 missense
Scores
9
10
Clinical Significance
Conservation
PhyloP100: 0.119
Genes affected
MYH13 (HGNC:7571): (myosin heavy chain 13) Predicted to enable microfilament motor activity. Predicted to be involved in muscle contraction. Predicted to act upstream of or within cellular response to starvation. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13334459).
BS2
High AC in GnomAd4 at 44 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH13 | NM_003802.3 | c.5124G>C | p.Gln1708His | missense_variant | 35/41 | ENST00000252172.9 | NP_003793.2 | |
LOC107985004 | XR_007065617.1 | n.96-8219C>G | intron_variant, non_coding_transcript_variant | |||||
LOC107985004 | XR_001752791.3 | n.96-8219C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH13 | ENST00000252172.9 | c.5124G>C | p.Gln1708His | missense_variant | 35/41 | 1 | NM_003802.3 | ENSP00000252172 | P1 | |
MYH13 | ENST00000621918.1 | c.5124G>C | p.Gln1708His | missense_variant | 33/39 | 1 | ENSP00000480864 | P1 | ||
ENST00000609088.1 | n.95-8219C>G | intron_variant, non_coding_transcript_variant | 4 | |||||||
MYH13 | ENST00000418404.8 | c.5124G>C | p.Gln1708His | missense_variant | 34/40 | 5 | ENSP00000404570 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152248Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
44
AN:
152248
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000808 AC: 20AN: 247640Hom.: 0 AF XY: 0.0000965 AC XY: 13AN XY: 134742
GnomAD3 exomes
AF:
AC:
20
AN:
247640
Hom.:
AF XY:
AC XY:
13
AN XY:
134742
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461474Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727070
GnomAD4 exome
AF:
AC:
42
AN:
1461474
Hom.:
Cov.:
31
AF XY:
AC XY:
21
AN XY:
727070
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000289 AC: 44AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74508
GnomAD4 genome
AF:
AC:
44
AN:
152366
Hom.:
Cov.:
33
AF XY:
AC XY:
19
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
8
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
11
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.5124G>C (p.Q1708H) alteration is located in exon 35 (coding exon 33) of the MYH13 gene. This alteration results from a G to C substitution at nucleotide position 5124, causing the glutamine (Q) at amino acid position 1708 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;N
REVEL
Uncertain
Sift
Benign
.;.;T
Sift4G
Benign
T;T;T
Polyphen
D;D;D
Vest4
MutPred
Gain of catalytic residue at L1710 (P = 0.0649);Gain of catalytic residue at L1710 (P = 0.0649);Gain of catalytic residue at L1710 (P = 0.0649);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at